cytarabine has been researched along with Myelodysplastic-Myeloproliferative Diseases in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chang, C; Fei, C; Gu, S; Guo, J; Li, X; Zhang, X; Zhang, Y; Zhao, Y | 1 |
1 other study(ies) available for cytarabine and Myelodysplastic-Myeloproliferative Diseases
| Article | Year |
|---|---|
Methylation of the p73 gene in patients with myelodysplastic syndromes: correlations with apoptosis and prognosis.
Topics: Adult; Aged; Apoptosis; Azacitidine; Bone Marrow Cells; Cells, Cultured; Cytarabine; Decitabine; DNA Methylation; DNA-Binding Proteins; Female; Humans; Male; Middle Aged; Myelodysplastic-Myeloproliferative Diseases; Nuclear Proteins; Prognosis; Promoter Regions, Genetic; Survival; Tumor Protein p73; Tumor Suppressor Proteins | 2013 |